Table of Contents
Journal of Biomarkers
Volume 2017 (2017), Article ID 4737082, 5 pages
https://doi.org/10.1155/2017/4737082
Research Article

The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin

1Department of Endocrinology, Diabetes and Metabolism, University Hospital of Basel, 4031 Basel, Switzerland
2Department of Clinical Pharmacology, University Hospital of Basel, 4031 Basel, Switzerland

Correspondence should be addressed to Svetlana Beglinger

Received 27 March 2017; Accepted 2 May 2017; Published 1 June 2017

Academic Editor: Kasper Karmark Iversen

Copyright © 2017 Svetlana Beglinger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann, “Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin,” Clinical Chemistry, vol. 52, no. 1, pp. 112–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Szinnai, N. G. Morgenthaler, K. Berneis et al., “Changes in plasma copeptin, the C-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 10, pp. 3973–3978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Jochberger, N. G. Morgenthaler, V. D. Mayr et al., “Copeptin and arginine vasopressin concentrations in critically Ill patients,” Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 11, pp. 4381–4386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. Robertson, “Antidiuretic hormone: normal and disordered function,” Endocrinology and Metabolism Clinics of North America, vol. 30, no. 3, pp. 671–694, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Reichlin, W. Hochholzer, C. Stelzig et al., “Incremental value of copeptin for rapid rule out of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 1, pp. 60–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. De Marchis, M. Katan, A. Weck et al., “Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk Study,” International Journal of Stroke, vol. 8, no. 3, pp. 214–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Lin, N. Wang, Z.-P. Shen, and Z.-Y. Zhao, “Plasma copeptin concentration and outcome after pediatric traumatic brain injury,” Peptides, vol. 42, pp. 43–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. Nickel, R. Bingisser, and N. G. Morgenthaler, “The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department,” BMC Medicine, vol. 10, article 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. N. G. Morgenthaler, J. Struck, S. Jochberger, and M. W. Dünser, “Copeptin: clinical use of a new biomarker,” Trends in Endocrinology and Metabolism, vol. 19, no. 2, pp. 43–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Battista, U. Audisio, C. Galluzzo et al., “Assessment of Diagnostic and Prognostic Role of Copeptin in the Clinical Setting of Sepsis,” BioMed Research International, vol. 2016, Article ID 3624730, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. K. H. Darzy, K. C. Dixit, S. M. Shalet, N. G. Morgenthaler, and G. Brabant, “Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment,” Clinical Chemistry, vol. 56, no. 7, pp. 1190-1191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Forsling, H. Montgomery, D. Halpin, R. J. Windle, and D. F. Treacher, “Daily patterns of secretion of neurohypophysial hormones in man: Effect of age,” Experimental Physiology, vol. 83, no. 3, pp. 409–418, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Dickmeis, “Glucocorticoids and the circadian clock,” Journal of Endocrinology, vol. 200, no. 1, pp. 3–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kalsbeek, F. Kreier, E. Fliers, H. P. Sauerwein, J. A. Romijn, and R. M. Buijs, “Minireview: circadian control of metabolism by the suprachiasmatic nuclei,” Endocrinology, vol. 148, no. 12, pp. 5635–5639, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. T. Uchoa, G. Aguilera, J. P. Herman, J. L. Fiedler, T. Deak, and M. B. C. de Sousa, “Novel aspects of glucocorticoid actions,” Journal of Neuroendocrinology, vol. 26, no. 9, pp. 557–572, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Collomp, A. Baillot, H. Forget, A. Coquerel, N. Rieth, and N. Vibarel-Rebot, “Altered diurnal pattern of steroid hormones in relation to various behaviors, external factors and pathologies: a review,” Physiology and Behavior, vol. 164, pp. 68–85, 2016. View at Publisher · View at Google Scholar · View at Scopus